BMO's initiation adds another bullish voice to an already crowded long consensus, but the heavy insider selling and negative EPS revision trend warrant caution. Traders should watch for a catalyst to close the gap between the $107 price and the ~$196 mean target, but avoid chasing into insider distribution.
INSM drugs
INSM drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 21 $108.62entry
- T+1 · 4mo ago −1.82%α −1.71% · $106.64
- T+5 · 4mo ago −3.58%α −2.35% · $104.73
- T+20 · 3mo ago +18.27%α +15.70% · $128.46
- T+60 · 5w ago −10.89%α −14.86% · $96.79
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BMO Capital initiated coverage on INSM at Outperform with a $192 price target, implying 78.6% upside from the current $107.56. The firm has a 53% accuracy rate on 1,842 calls with a 2.3% average return, placing it in the middle tier among firms covering INSM. Consensus is overwhelmingly bullish, 28 of 29 analysts rate Buy or Strong Buy, with only 1 Hold and zero Sell ratings. The mean price target is $196.38, median $200, high $243, low $140. BMO's $192 target is slightly below the mean but still well above current levels. Momentum is positive: 1 upgrade and 0 downgrades in the last 30 days, though EPS revisions for the current fiscal year show 4 downward revisions vs 0 upward. Insider selling is notable, two C-suite members sold over $2.6M in July, but institutional buying is strong, with several funds adding or doubling positions. The initiation from a mid-tier firm adds modest bullish confirmation to an already crowded long consensus.
Impact Score
Consensus & Targets
Consensus is 28 Buy/Strong Buy (97%), 1 Hold (3%), 0 Sell/Strong Sell. 29 analysts cover the stock. Direction is strongly bullish, with only one hold rating.
Mean PT $196.38, median $200, high $243, low $140. Current price $107.56 implies 82.6% upside to the mean. BMO's $192 PT is 2.2% below the mean, in line with the bullish consensus.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-21 | BMO Capital | initiate | Outperform | $192.00 |
| 2026-07-15 | Wells Fargo | maintain | Overweight | $161.00 |
| 2026-07-10 | Guggenheim | reiterate | Buy | $207.00 |
| 2026-06-22 | Evercore ISI Group | maintain | Outperform | $160.00 |
| 2026-06-08 | JP Morgan | maintain | Overweight | $179.00 |
| 2026-06-05 | RBC Capital | maintain | Outperform | $195.00 |
| 2026-05-14 | Truist Securities | maintain | Buy | $185.00 |
| 2026-05-08 | RBC Capital | maintain | Outperform | $205.00 |
| 2026-05-08 | Wells Fargo | maintain | Overweight | $160.00 |
| 2026-05-08 | Guggenheim | maintain | Buy | $226.00 |
30-day analyst activity: 1 upgrade (this initiation), 0 downgrades. EPS revisions: current quarter (0q) had 1 up and 1 down revision in 30 days, neutral. Current fiscal year (0y) had 0 up and 4 down revisions. Next fiscal year (+1y) had 2 up and 3 down revisions. Net revision trend is slightly negative.
Firm Track Record: BMO Capital
BMO Capital accuracy: 53% on 1842 calls | avg return: 2.3%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Barclays | 100% | 2/2 | 106.1% | top tier |
| Jefferies | 100% | 2/2 | 71.2% | top tier |
| B of A Securities | 75% | 6/8 | 23.2% | top tier |
| JP Morgan | 71% | 5/7 | 24.8% | top tier |
| Truist Securities | 70% | 7/10 | 54.4% | top tier |
| Wells Fargo | 67% | 6/9 | 37.2% | top tier |
| Mizuho | 67% | 4/6 | 46.5% | top tier |
| HC Wainwright & Co. | 64% | 9/14 | 31.2% | top tier |
| UBS | 63% | 5/8 | 27.6% | top tier |
| Morgan Stanley | 63% | 5/8 | 54.8% | top tier |
BMO Capital has a 53% accuracy rate on 1,842 scored calls with a 2.3% average return, middle tier among firms covering INSM. Top-tier firms by accuracy on this stock include Barclays (100% on 2 calls), Jefferies (100% on 2), and BofA (75% on 8). Bottom-tier: Cantor Fitzgerald (40% on 5, -9.8% avg return) and TD Cowen (33% on 6, -0.4% avg return).
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $-0.69 | $-1.09 to $-0.05 | $393.0M | ↑0 ↓0 |
| 0y | $-2.59 | $-4.29 to $-1.60 | $1.7B | ↑0 ↓0 |
| +1q | $-0.61 | $-1.14 to $-0.30 | $465.8M | ↑0 ↓0 |
| +1y | $0.13 | $-2.24 to $1.64 | $2.8B | ↑1 ↓0 |
Cross-Platform Signals
Insider selling: C-suite members Lewis William (EVP) sold ~$1.26M on July 9 and Flammer Martina M.D. (likely C-suite) sold ~$1.35M on July 6, total $2.6M+ in insider sales. This is a bearish signal. Congressional activity: Rep. Josh Gottheimer (D) sold $1K-$15K on June 10, negligible. Institutional buying is strong: Ameriprise added 55.3% ($500M position), Assenagon doubled (+245%, $23.3M), Walleye Capital quadrupled (+354%, $11.7M). Short interest is 56.5% of TRF volume, elevated. The insider selling diverges from the bullish analyst signal, but institutional buying converges with it.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
24 reports on INSM
4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +31.86% at T+60 after the Mar 30, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $111.59 Now $122.88 +10.12% settles Nov 27
- Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $94.04 Now $122.88 +30.67% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 3/10 Entry $95.67 Now $122.88 +28.44% settles Nov 17
- Oct 5, 20266w ago 8-K Neutral 4/10 Entry $103.83 to $112.58 Now $122.88 +18.35% ▲ +8.43% +10.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 4/10 Entry $125.08 to $120.00 Now $122.88 −1.76% ▼ −4.06% −4.19% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $126.33 to $129.41 Now $122.88 −2.73% ▲ +2.44% +4.19% vs SPY
- Aug 6, 202614w ago 8-K Bullish 8/10 Entry $132.55 to $126.68 Now $122.88 −7.30% ▼ −4.43% −5.03% vs SPY
- Jul 24, 202616w ago Institutional Cluster Neutral 4/10 Entry $106.92 to $125.77 Now $122.88 +14.93% ▲ +17.63% +14.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers